OptiBiotix Health (LON:OPTI) Stock Price Down 11% – Time to Sell?

OptiBiotix Health Plc (LON:OPTI)’s stock price fell 11% during trading on Friday . The company traded as low as GBX 6.05 and last traded at GBX 6.05. Approximately 550,420 shares changed hands during trading, an increase of 56% from the average daily volume of 352,512 shares. The stock had previously closed at GBX 6.80.

OptiBiotix Health Trading Down 11.0%

The firm has a market cap of £6.25 million, a price-to-earnings ratio of -1.58 and a beta of 1.82. The firm’s 50 day simple moving average is GBX 5.80 and its two-hundred day simple moving average is GBX 5.73.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.